PIBIS clinical decision support for Clinical Decision Support

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Clinical Decision Support+4 More
PIBIS clinical decision support - Other
Eligibility
< 18
All Sexes
What conditions do you have?
Select

Study Summary

This trial is to see if the PIBIS can help identify which infants have a higher risk for AHT.

Eligible Conditions
  • Clinical Decision Support
  • Injuries, Brain
  • Infants

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 4 Secondary · Reporting Duration: From enrollment to 6 months following hospital discharge

Month 6
The number of enrolled children who return to the ED within 6 months of enrollment and undergo neuroimaging.
From enrollment to hospital discharge, up to one month
Eligibility confirmation
Proportion of all children with each PIBIS score who are ultimately diagnosed with physical abuse by the CHP Child Protection Team
Proportion of children who undergo neuroimaging (head CT or brain MRI) during the control and intervention periods
Proportion of children with PIBIS calculation and recommendations
Proportion of neuroimaging which demonstrates an abnormality during the control and intervention periods

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Control Arm
1 of 2
Intervention Arm
1 of 2
Active Control
Experimental Treatment

609 Total Participants · 2 Treatment Groups

Primary Treatment: PIBIS clinical decision support · No Placebo Group · N/A

Intervention Arm
Other
Experimental Group · 1 Intervention: PIBIS clinical decision support · Intervention Types: Other
Control Arm
Other
ActiveComparator Group · 1 Intervention: Standard of care · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: from enrollment to 6 months following hospital discharge

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,600 Previous Clinical Trials
6,285,106 Total Patients Enrolled
The Beckwith InstituteUNKNOWN
1 Previous Clinical Trials
120 Total Patients Enrolled
Rachel Berger, MDPrincipal InvestigatorUniversity of Pittsburgh
1 Previous Clinical Trials
351 Total Patients Enrolled

Eligibility Criteria

Age < 18 · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
The child has been having problems with apnea, being fussy or irritable, being lethargic, and having a neurologic complaint
: Children aged 30 days to less than 1 year can be vaccinated against pertussis.
The first temperature in the ED is less than or equal to 38.3C.
The person's acuity level is 3, 4, or 5.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 12th, 2021

Last Reviewed: October 22nd, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.